Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 12, 2025

Core Viewpoint - Alkermes plc will host a conference call and webcast on February 12, 2025, to discuss its fourth quarter and year-end 2024 financial results, along with financial expectations for 2025 and company updates [1]. Company Overview - Alkermes plc is a global biopharmaceutical company focused on developing innovative medicines in neuroscience, with a portfolio addressing alcohol dependence, opioid dependence, schizophrenia, and bipolar I disorder [3]. - The company has a pipeline of clinical and preclinical candidates targeting neurological disorders, including narcolepsy and idiopathic hypersomnia [3]. - Alkermes is headquartered in Ireland, with additional offices and facilities in Massachusetts and Ohio [3].